Bausch + Lomb (NYSE: BLCO – Get Rating) and STAAR Surgical (NASDAQ: STAA – Get Rating) are both mid-cap medical companies, but which is the better company? We will compare the two companies based on their risk strength, analyst recommendations, institutional ownership, earnings, valuation, dividends and profitability.
This table compares the net margins, return on equity and return on assets of Bausch + Lomb and STAAR Surgical.
|Net margins||Return on equity||return on assets|
|Bausch + Lomb||N / A||N / A||N / A|
This is a breakdown of recent ratings and target prices for Bausch + Lomb and STAAR Surgical, as provided by MarketBeat.
|Sales Ratings||Hold odds||Buy reviews||Strong buy odds||Rating|
|Bausch + Lomb||0||4||8||0||2.67|
Bausch + Lomb currently has a consensus target price of $23.10, indicating a potential upside of 40.60%. STAAR Surgical has a consensus target price of $92.00, indicating a potential upside of 15.10%. Given Bausch + Lomb’s likely higher upside, stock analysts clearly believe that Bausch + Lomb is more favorable than STAAR Surgical.
Insider and Institutional Ownership
89.9% of STAAR Surgical shares are held by institutional investors. 3.6% of the shares of STAAR Surgical are held by insiders of the company. Strong institutional ownership indicates that large fund managers, endowments, and hedge funds believe a company will outperform the market over the long term.
Valuation and benefits
This chart compares gross revenue, earnings per share (EPS), and valuation of Bausch + Lomb and STAAR Surgical.
|Gross revenue||Price/sales ratio||Net revenue||Earnings per share||Price/earnings ratio|
|Bausch + Lomb||$3.77 billion||1.53||$182.00 million||N / A||N / A|
|STAAR surgery||$230.47 million||16.58||$24.50 million||$0.58||137.81|
Bausch + Lomb has higher revenue and profit than STAAR Surgical.
STAAR Surgical beats Bausch + Lomb on 7 of the 11 factors compared between the two actions.
Company Profile Bausch + Lomb (Get a rating)
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care/Consumer Healthcare, Ophthalmic Pharmaceuticals and Surgery. The Vision Care/Consumer Health Care segment provides contact lenses that cover the spectrum of wearing modalities, including daily and frequently replaced disposable contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that treat a variety of conditions, including eye allergies, conjunctivitis, and dry eyes. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceuticals for postoperative treatments and treatments for various eye conditions, such as glaucoma, ocular inflammation, ocular hypertension, dry eye and retinal diseases; and contact lenses for therapeutic use. The Surgery segment provides medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal conditions, cataracts and vitreous and retinal eye conditions. The company was founded in 1853 and is headquartered in Vaughan, Canada.
STAAR Surgical Company Profile (Get a rating)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets and sells implantable lenses for the eye and companion delivery systems for introducing the lenses into the eye. The Company provides the Visian line of implantable Collamer Lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism and presbyopia; and Hyperopic ICL, which treats farsightedness. It also offers preloaded silicone intraocular lenses for cataracts and injection systems for cataract surgery. In addition, the Company sells parts of injectors and other related instruments and devices. It markets its products to healthcare providers, including eye surgeons, vision and surgical centers, hospitals, government facilities and distributors, as well as products primarily used by ophthalmologists. The Company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom and Singapore, as well as through its own representatives and independent distributors in China, Korea, India, France, Benelux, Italy and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Get news and reviews for Bausch + Lomb Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Bausch + Lomb and related companies with MarketBeat.com’s FREE daily email newsletter.